The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

The FDA-approved medications for weight loss and diabetes remain a life-changing therapy in many countries, and for some individuals, it is an affordable luxury. Let's delve deep into how prices vary ...

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...

“Lifestyle changes are associated with modest improvements in sperm motility and morphology, even though the amount of weight ...

New research shows that a new weight-loss drug called MariTide might offer a powerful alternative to current weekly ...

A groundbreaking study has compared the three top weight loss medications on the market, which has produced some surprising ...

Popular weight-loss drugs like Ozempic and Zepbound may offer more than just help shedding extra pounds—they might also help protect people from serious health risks linked to sleep apnea. That’s the ...